Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07071207 · ClinicalTrials.gov registry record · NA

Effect of Text Message Reminders on M-ISI Score After Prostate Surgery

A NA study of Prostate Cancer and Benign Prostate Hyperplasia, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
132
Enrollment target
1
Study location

NCT07071207 is a NA study of Prostate Cancer and Benign Prostate Hyperplasia that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 132 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07071207, a NA study of Prostate Cancer and Benign Prostate Hyperplasia, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
132 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare post-prostatectomy incontinence via Michigan Incontinence Score Index in patients receiving daily text message reminders for pelvic floor exercises when compared to those not receiving text reminders.

Interventions

  • BEHAVIORAL Text message reminders

Study Locations (1)

New York

  • 158 Sawgrass clinic; Suite 3100 - Rochester

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 2025-09-15
Est. Completion 2028-05-01
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT07071207

The ClinicalTrials.gov registry entry for NCT07071207 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (78% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Text message reminders is the first listed.

NCT07071207 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07071207 about?

NCT07071207 is a clinical study titled "Effect of Text Message Reminders on M-ISI Score After Prostate Surgery". The purpose of this study is to compare post-prostatectomy incontinence via Michigan Incontinence Score Index in patients receiving daily text message reminders for pelvic floor exercises when compared to those not receiving text reminders.

What is the current status of trial NCT07071207?

This trial is currently recruiting. It is a NA study. The enrollment target is 132 participants. The study started on 2025-09-15. Estimated completion is 2028-05-01.

What conditions does trial NCT07071207 study?

This clinical trial studies the following conditions: Prostate Cancer, Benign Prostate Hyperplasia, Incontinence, Urinary Stress.

What interventions are being tested in trial NCT07071207?

The interventions under investigation include: Text message reminders (BEHAVIORAL).

Who is sponsoring clinical trial NCT07071207?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07071207 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.